Panel: The Great Comeback: Reshoring Realities, Lessons, and Wins

Join industry leaders in this candid panel as we unpack the bold shift to bring pharmaceutical manufacturing back to the US. Drugmakers have committed hundreds of billions in domestic projects, led by pledges like Johnson & Johnson's $55 billion, AstraZeneca's $50 billion, and Roche's $50 billion, to counter tariffs, secure supply chains, and tap policy incentives. We'll get real on the challenges: strategic site selection amid talent shortages, workforce development, scaling advanced technologies like continuous manufacturing, and juggling costs, speed, and compliance. Hear firsthand how companies leverage government incentives, regional partnerships, and innovative approaches to boost security and edge. Attendees will leave with practical, actionable strategies to evaluate reshoring moves, overcome obstacles, and position their organizations for lasting success in this high-stakes, evolving American pharma landscape.